Cyrus Karkaria
Corporate Officer/Principal at LUPIN LIMITED
Profile
Cyrus Karkaria is currently the President-Biotechnology at Lupin Ltd.
He was previously the Vice President-BPS & Operations at CuraGen Corp.
Karkaria holds a doctorate degree from the University of Maryland, a graduate degree from the University of Mumbai, and a graduate degree from Harvard Medical School.
Cyrus Karkaria active positions
| Companies | Position | Start |
|---|---|---|
| LUPIN LIMITED | Corporate Officer/Principal | 06/10/2011 |
Former positions of Cyrus Karkaria
| Companies | Position | End |
|---|---|---|
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | - |
Training of Cyrus Karkaria
| University of Maryland | Doctorate Degree |
| University of Mumbai | Graduate Degree |
| Harvard Medical School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LUPIN LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
- Stock Market
- Insiders
- Cyrus Karkaria
